Ascend Performance Materials Operations LLC manufactures and supplies nylon chemicals. The company is headquartered in Houston, TX.

Tayca Corp. engages in the manufacture and sale of industrial chemical products. It operates through the following segments: Functional Materials, Electronic Materials and Chemical Products, and Others. The Functional Materials segment covers Titanium oxide, fine particle titanium oxide, fine particle zinc oxide, and surface treatment products. The Electronic Materials and Chemical Product segment handles piezoelectric materials, conductive polymer chemicals, surfactants, sulfuric acid, and pollution-free rust preventive pigments. The Others segment includes warehousing and engineering business. The company was founded on December 22, 1919 and is headquartered in Osaka, Japan.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

Xuanzhu (Beijing) Pharmaceutical Technology Co., Ltd., established on 2018-12-10, The scope of business includes new technologies in pharmaceutical and chemical industries,Technology development of new pharmaceutical products,technology transfer,Technical Services;Business Consulting;Trade Consulting;Technology Import and Export;commissioned drug production;production of medicines(Does not contain chemical raw materials,Chinese Proprietary Medicine and Chinese Herbal Pieces,Veterinary Drugs).(Market entities independently choose business projects in accordance with the law,Carry out business activities;production of medicines(Does not contain chemical raw materials,Chinese Proprietary Medicine and Chinese Herbal Pieces,Veterinary Drugs)and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Cipla USA, Inc., part of Cipla Ltd., is a company headquartered in Warren, NJ, that manufactures pharmaceutical products. It was founded in 1984. Arunesh Verma is currently the CEO of the firm.

Guangdong Qingda Zhixing Biotechnology Co., Ltd., established on 2017-01-20, Business scope includes research and development of bioenergy technology and transfer of technological achievements,Biochemical products,Textile Chemical Raw Materials,Research and development of non-edible oil products,Production,Sales and development of related technologies and equipment,Transfer and Consulting Services;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Taizhou City Zhedong Medical Care Investment Management Co., Taizhou Municipal Hospital Co. Ltd. is a Chinese company that operates a hospital.

Qu Biologics is developing a platform of new immunotherapeutic treatments. Our Site Specific Immunomodulators (SSIs) aim to activate the body’s immune system to reverse the chronic inflammation underlying many conditions including cancer and immune-related diseases, such as Crohn’s disease. More than 270 patients with advanced cancer and moderate-to-severe immune-related disease have been treated with Qu Biologics’ SSIs through a compassionate use program. The preliminary findings suggest some promising outcomes which support further research in controlled clinical trials. Currently, we are recruiting for a Phase 1/2 clinical trial in Crohn’s disease. More information on this Crohn’s disease research trial can be found at www.qucrohnstrial.com. Qu Biologics’ goal is to develop SSIs to improve the survival and quality of life of millions of people fighting cancer and the quality of life of people living with debilitating immune-related diseases such as Crohn’s disease, ulcerative colitis and rheumatoid arthritis. - See more at: http://www.qubiologics.com/#sthash.tKIA4N2Z.dpuf

Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections. The company's most advanced drug candidate, ACHN-490, has demonstrated a positive safety and dosing profile in Phase 1 clinical testing and displayed broad spectrum efficacy in preclinical studies against systemic infections caused by multi-drug resistant (MDR) Gram-negative bacteria (e.g., E. coli, K. pneumoniae, and P. aeruginosa) and MRSA. In addition, the company is pursuing preclinical programs in several other areas of interest to combat the global emergence of bacterial resistance.

Xiamen Bojia Biotechnology Co., Ltd., established on 2008-06-04, Business scope includes1,biomedical equipment,Technical research and development of teaching experimental equipment;2,Information Technology Consulting(Internet access service and information service are not included);3,wholesale,retail:experiment apparatus,Equipment,Electronic equipment,Biological reagents and consumables(Does not contain drugs,food,Hazardous and controlled chemicals, etc., which must be approved),Chemical reagents and consumables(Free of hazardous chemicals and controlled chemicals).

Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.

Genecor, Inc. provides engineering services. The company is headquartered in Quebec City, Canada.

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus) induced skin and soft tissue infections.

Sinopec Corp. Fushun Petrochemical Research Institute, established on 2000-04-14, Business scope includes technology and information research,to develop,application,consultation service;Petrochemical products researched and developed by our institute(Free of Hazardous Chemicals)Production,Sales,Petroleum and petrochemical equipment manufacturing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.